NAV

Etoglucid

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Etoglucid
DrugBank Accession Number
DB13339
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
3D
Similar Structures
Weight
Average: 262.302
Monoisotopic: 262.141638428
Chemical Formula
C12H22O6
Synonyms
  • Etoglucid
Poor quality drug data slowing you down?
Unlock 38% more drug discovery time and eliminate decision-making doubts with this one-stop guide to quality drug data.
Download eBook
Poor quality drug data slowing you down?
Download eBook

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
Integrate drug-drug
interactions in your software
AmbroxolThe risk or severity of methemoglobinemia can be increased when Etoglucid is combined with Ambroxol.
ArticaineThe risk or severity of methemoglobinemia can be increased when Etoglucid is combined with Articaine.
BenzocaineThe risk or severity of methemoglobinemia can be increased when Etoglucid is combined with Benzocaine.
Benzyl alcoholThe risk or severity of methemoglobinemia can be increased when Etoglucid is combined with Benzyl alcohol.
BupivacaineThe risk or severity of methemoglobinemia can be increased when Etoglucid is combined with Bupivacaine.
Food Interactions
Not Available

Categories

ATC Codes
L01AG01 — Etoglucid
Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as epoxides. These are compounds containing a cyclic ether with three ring atoms(one oxygen and two carbon atoms).
Kingdom
Organic compounds
Super Class
Organoheterocyclic compounds
Class
Epoxides
Sub Class
Not Available
Direct Parent
Epoxides
Alternative Parents
Oxacyclic compounds / Dialkyl ethers / Hydrocarbon derivatives
Substituents
Aliphatic heteromonocyclic compound / Dialkyl ether / Ether / Hydrocarbon derivative / Organic oxygen compound / Organooxygen compound / Oxacycle / Oxirane
Molecular Framework
Aliphatic heteromonocyclic compounds
External Descriptors
epoxide (CHEBI:82542)
Affected organisms
Not Available

Chemical Identifiers

UNII
4F9KUA0T4D
CAS number
1954-28-5
InChI Key
UMILHIMHKXVDGH-UHFFFAOYSA-N
InChI
InChI=1S/C12H22O6/c1(13-3-5-15-7-11-9-17-11)2-14-4-6-16-8-12-10-18-12/h11-12H,1-10H2
IUPAC Name
2-[12-(oxiran-2-yl)-2,5,8,11-tetraoxadodecan-1-yl]oxirane
SMILES
C(COCCOCC1CO1)OCCOCC1CO1

References

General References
Not Available
KEGG Compound
C19537
ChemSpider
15246
RxNav
4132
ChEBI
82542
ChEMBL
CHEMBL460287
Wikipedia
Etoglucid

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility2.79 mg/mLALOGPS
logP-0.38ALOGPS
logP-0.33Chemaxon
logS-2ALOGPS
pKa (Strongest Basic)-3.4Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count6Chemaxon
Hydrogen Donor Count0Chemaxon
Polar Surface Area58.68 Å2Chemaxon
Rotatable Bond Count13Chemaxon
Refractivity63.63 m3·mol-1Chemaxon
Polarizability29.35 Å3Chemaxon
Number of Rings2Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterYesChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-0k9l-9510000000-853e6f5a8f2986fcae15
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-0002-3190000000-4a927c37ffdb59fbc74d
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-06si-7950000000-1474c3847e684eae4563
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-004j-1590000000-c06bfa250538790ec041
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-0002-0910000000-6830dfc7b6608b618821
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-05fr-9610000000-ceefdac23440e30a51d8
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-0a4m-6930000000-ea0155a6518526e43fea
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-155.01347
predicted
DeepCCS 1.0 (2019)
[M+H]+157.93535
predicted
DeepCCS 1.0 (2019)
[M+Na]+167.07947
predicted
DeepCCS 1.0 (2019)

Drug created at June 23, 2017 20:40 / Updated at February 21, 2021 18:54